MAMelek Akinci

Melek Akinci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melek Akinci has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effects of Epigallocatechin-3-Gallate in Preventing 5-Fluorouracil-induced Liver Injury in AML-12 Cell Line

    by Melek Akıncı, Çağatay Oltulu, Elvan Bakar, Zatiye Ayca Cevikelli Yakut

    This study aimed to assess the potential of epigallocatechin-3-gallate (EGCG) in mitigating 5-fluorouracil (5-FU)-induced hepatotoxicity using the AML12 cell line. In our study, we utilized the AML-12 cell line and divided it into four groups: control, 5-FU, EGCG, and EGCG+FU. The IC50 values were determined using the MTT assay. Expression levels of antioxidant system-associated genes, including Glutathione, catalase, and superoxide dismutase, were analyzed through qRT-PCR. Additionally, qRT-PCR analysis was employed to evaluate the expression of apoptosis-associated genes such as Caspase (Cas)-9, Apaf-1, Cas-3, Bax, and Bcl-2. Furthermore, the gene expressions of p53 and the smac/DIABLO were investigated. When EGCG was administered together with 5-FU GSH, SOD, and CAT mRNA expression levels increased. 5-FU administration statistically significantly elevated smac/DIABLO, Bax, Apaf-1, Bcl-2, and Cas-3 mRNA expression levels by stimulating apoptosis. When EGCG was administered together with 5-FU, Cas-9, Bax, Apaf-1, p53, Cas-3 and smac/DIABLO mRNA expressions elevated significantly, indicating the elimination of damaged structures through apoptosis. In conclusion, our findings indicate that EGCG confers hepatoprotective effects against 5-FU-induced damage through its antioxidant properties. Moreover, EGCG enhances the anticancer efficacy of 5-FU by promoting apoptosis, thereby facilitating the elimination of damaged cells. These results suggest a potential therapeutic synergy between EGCG and 5-FU in managing liver injury and cancer treatment.

  • Organ-specific effects of curcumin on favipiravir-induced oxidative stress: renal benefit and hepatic risk

    by Melek Akinci, Zatiye Ayca Cevikelli-Yakut, Elvan Bakar, Cagatay Oltulu

    Fa vipiravir (FAV), an antiviral for influenza and COVID-19, can provoke hepatotoxicity and nephrotoxicity. Curcumin (CUR) has antioxidant and anti-inflammatory properties that may protect against FAV-induced toxicity. Despite the widespread clinical use of FAV, to our knowledge, no in vivo animal study has yet examined its organ-specific oxidative injury profile in parallel with the putative dual, organ-directed actions of CUR. This study evaluated whether curcumin can mitigate favipiravir-induced oxidative and apoptotic damage in rat liver and kidney. Male Wistar rats received FAV (100 mg/kg i.p.) and CUR (100 or 200 mg/kg p.o.) for 14 days. Serum biochemistry analysis was performed to assess levels of ALT, AST, IL-6, MDA, TNF-α, and GSH. Additionally, histopathological examination and TUNEL assay were conducted on kidney and liver tissues. ALT, AST, and cytokines did not differ among groups. MDA remained unchanged in the FAV-alone group but rose significantly with CUR co-treatment, signifying CUR-driven amplification of oxidative stress, especially in hepatic tissue. Histopathological analysis revealed liver and kidney damage from FAV, with CUR exacerbating liver damage but offering partial protection to kidney structures. The TUNEL assay showed reduced apoptosis in the kidneys with CUR, especially at higher doses. FAV causes sub-clinical liver and kidney injury that is not accompanied by lipid peroxidation or enzyme leakage at 14 days. CUR exerts dual actions—mitigating renal apoptosis yet amplifying hepatic lipid peroxidation—highlighting an organ-specific risk–benefit ratio that should be weighed before empirical antioxidant supplementation during FAV therapy.

  • Galanginin Protects AML-12 Cells Against Dactinomycin Induced Hepatotoxicity

    by Melek Akinci, Çağatay Oltulu, Elvan Bakar, Zatiye Ayça Çevi̇kelli̇ Yakut


  • Puerarin Protects from Methotrexate Induced Hepatotoxicity in AML-12 Cells

    by Melek Akinci, Çağatay Oltulu, Elvan Bakar, Zatiye Ayça Çevi̇kElli̇ Yakut


  • Topotekan, karvakrol, epigallokateşin gallat ve kombinasyonlarının nöroblastom ve astrosit hücrelerinde apoptotik süreç üzerine etkisinin değerlendirilmesi

    by Çağatay Oltulu, Melek Akinci, Elvan Bakar

    Neuroblastoma is the sympathetic nervous system cancer. It most commonly affects children under 5 years of age and is the most common solid tumor in childhood. Topotecan is a topoisomerase 1 inhibitor. Carvacrol and Epigallocatechin gallate are naturally derived substances with anticancer, antioxidant, and apoptotic properties. The aim of our study was to evaluate the effects of topotecan, carvacrol, EGCG, topotecan+carvacrol, and topotecan+ epigallocatechin gallate combinations on the apoptotic signaling pathway. IC50 values were determined in neuroblastoma and healthy astrocyte cells using the MTT assay. Apoptotic mRNA expressions (topoisomerase 1 and 2, p53, BCL2, BAX, caspase 9, caspase 3, IL1, TNFα) in astrocytes and neuroblastoma cells at the neuroblastoma IC50 dose were analyzed using quantitative real-time PCR. We found that topotecan and carvacrol did not exhibit selective cytotoxic effects between healthy astrocytes and neuroblastoma cells. However, we found that the combination of topotecan+ epigallocatechin gallate and topotecan+carvacrol with epigallocatechin gallate showed selective cytotoxic effects on the neuroblastoma cell line compared to astrocyte cells. The obtained mRNA results can be interpreted as the initiation of apoptosis in neuroblastoma cells in the topotecan, carvacrol, epigallocatechin gallate, and topotecan+epigallocatechin gallate groups. Further studies are needed to investigate this matter in more detail.

  • Antitumor Activity of Etoposide, Puerarin, Galangin and Their Combinations in Neuroblastoma Cells

    by Çağatay Oltulu, Melek Akinci, Elvan Bakar

    Neuroblastoma is a disease that is observed in early childhood, originating from the sympathetic nervous system and very difficult to treat. Etoposide, a topoisomerase 2 inhibitor, is one of the agents used in cancer treatment. Galangin and puerarin are plant-based antioxidants with anticancer properties. Since apoptosis induction is one of the methods used in cancer treatment, the evaluation of the mRNA expression levels of apoptosis-related genes is aimed in our study. We investigated the effects of etoposide and galangin/puerarin combination therapy on neuroblastoma and astrocyte cells’ apoptotic process in this study. IC50 dose was determined by MTT test in neuroblastoma and healthy astrocyte lines. Apoptosis-related mRNA gene expressions (topoisomerase 1 and 2α, BAX, p53, TNFα, BCL-2, caspase 3, IL-1, caspase 9) were evaluated in astrocyte and neuroblastoma cells at the dose of neuroblastoma IC50. It was resulted that in all groups, the neuroblastoma IC50 dose was lower than the healthy astrocyte cell IC50 dose and while an increase in apoptotic mRNA expressions was observed in the neuroblastoma cancer line, the mRNA expression changes in the astrocyte cell line did not cause apoptosis. Etoposide combinations antiproliferative effect was decreased relative to etoposide group. It is concluded that single therapy of galangin and puerarin may be promising in the treatment of neuroblastoma.


  • Evaluation of Genotoxicity Risk in Health Care Workers Exposed to Antineoplastic Drugs

    by Cagatay Oltulu, Tugce Yesi̇l Deveci̇oGlu, Melek Aki̇nCi̇, Sevcan Gul Akgun Olmez, Serra Vildan Obei̇dİn, Ayfer Beceren

    Objective: DNA damage that can be caused by workplace exposure to antineoplastic drugs in health workers has been shown in many scientific studies. It is aimed to evaluate whether the risk of genotoxicity in health workers decreases after the regulations and measures taken by national and international health authorities in our work.Methods: For this purpose, DNA damage was assessed by using alkaline comet technique in lymphocytes isolated from blood samples of health workers (n=29) who were involved in preparing and / or administering antineoplastic agent at Trakya University Health Research and Application Center and compared with the control group (n=30). Also, those who prepare and/or administer antineoplastic agents; (n=16) and manual (n=13) preparations.Results: As a result of the evaluation, there was no statistically significant difference between health personnel and control group in preparing and / or administering antineoplastic agent (p>0,05, Mann-Whitney U) and there was no difference in the genotoxic risk between preparation forms. Furthermore, when the exposed control group was assessed for DNA damage as smokers and nonsmokers, there was no statistically significant difference in terms of DNA damage (p>0.05).Conclusion: At the center where our samples were taken, the resulting measures resulted in the control of the risk of genotoxicity due to occupational exposure to antineoplastic agents.


  • Open Access

    Effects of in vitro Amitriptyline, Fluoxetine, Tranylcypromine and Venlafaxine on Saphenous Vein Grafts

    by Melek Akinci, Cetin Hakan Karadag, Serhat Huseyin, Cagatay Oltulu, Suat Canbaz, Ozgur Gunduz, Ruhan Deniz Topuz

    Objective: In this study, we aimed to examine the effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on saphenous vein grafts in coronary artery bypass graft surgeries. Methods: 59 patients (40 males and 19 females; mean age 65.1 years, distribution: 45-84 years) who had coronary artery bypass graft surgery between February 2014 and May 2016 were included in the study. After the saphenous vein grafts with intact and denuded endothelium were precontracted with 3x10(-6)M phenylephrine, amitriptyline, fluoxetine and tranylcypromine were cumulatively added to isolated organ baths in the range of 10(-11)-3x10(-5)M, while venlafaxine was added in the range of 10(-9)-3x10(-5)M. Then, the antidepressant-induced relaxation responses were recorded isometrically. Results: While the relaxation response of amitriptyline at -6.42 (Log M) was 74.6%, the response at -6.32 (Log M) was 75.5%. While the relaxation response at -6.46 (Log M) of fluoxetine was 68.02%, the response at -6.02 (Log M) was 72.12%. While the relaxation response of tranylcypromine at -7.53 (Log M) was 61.13%, the response at -7.23 (Log M) was 65.53%. While the relaxation response of venlafaxine at -6.21 (Log M) was 29.98%, the response at -5.90 (Log M) was 32.96%. Conclusion: The maximum relaxation at minimum and maximum therapeutic concentrations was obtained with amitriptyline, fluoxetine and tranylcypromine, and the minimum relaxation was obtained with venlafaxine. The relaxation responses were independent of the endothelium.